296 related articles for article (PubMed ID: 23082215)
1. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
Wang X; Li YM; Li WQ; Huang CG; Lu YC; Hou LJ
PLoS One; 2012; 7(10):e47778. PubMed ID: 23082215
[TBL] [Abstract][Full Text] [Related]
2. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Song J; Xue YQ; Wang YJ; Xu P; Sun DK; Chen W
World Neurosurg; 2019 Mar; 123():e235-e244. PubMed ID: 30496924
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
Shen J; Pan JW; Fan ZX; Xiong XX; Zhan RY
J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
[TBL] [Abstract][Full Text] [Related]
4. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
[TBL] [Abstract][Full Text] [Related]
5. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
[TBL] [Abstract][Full Text] [Related]
6. Clazosentan for Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis with Trial Sequential Analysis.
Cho SS; Kim SE; Kim HC; Kim WJ; Jeon JP
World Neurosurg; 2019 Mar; 123():418-424.e3. PubMed ID: 30508597
[TBL] [Abstract][Full Text] [Related]
7. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
Lancet Neurol; 2011 Jul; 10(7):618-25. PubMed ID: 21640651
[TBL] [Abstract][Full Text] [Related]
8. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
[TBL] [Abstract][Full Text] [Related]
9. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
Mayer SA; Aldrich EF; Bruder N; Hmissi A; Macdonald RL; Viarasilpa T; Marr A; Roux S; Higashida RT
Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor antagonists for subarachnoid hemorrhage.
Guo J; Shi Z; Yang K; Tian JH; Jiang L
Cochrane Database Syst Rev; 2012 Sep; (9):CD008354. PubMed ID: 22972119
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
Vergouwen MD; Algra A; Rinkel GJ
Stroke; 2012 Oct; 43(10):2671-6. PubMed ID: 22871682
[TBL] [Abstract][Full Text] [Related]
12. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
Acta Neurochir Suppl; 2013; 115():27-31. PubMed ID: 22890639
[TBL] [Abstract][Full Text] [Related]
13. Different Doses of Clazosentan for Aneurismal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.
Rong WL; Xiao X; Zhao JL; Yang XW; Hu ZL; Li MH
Am J Ther; 2018; 25(6):e652-e660. PubMed ID: 26752653
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Clazosentan After Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis.
Pontes JPM; Santos MDC; Gibram FC; Rodrigues NMV; Cavalcante-Neto JF; Barros ADM; Solla DJF
Neurosurgery; 2023 Dec; 93(6):1208-1219. PubMed ID: 37462365
[TBL] [Abstract][Full Text] [Related]
15. Reversal of Vasospasm with Clazosentan After Aneurysmal Subarachnoid Hemorrhage: A Pilot Study.
Higashida RT; Bruder N; Gupta R; Guzman R; Hmissi A; Marr A; Mayer SA; Roux S; Weidauer S; Aldrich EF
World Neurosurg; 2019 Aug; 128():e639-e648. PubMed ID: 31054336
[TBL] [Abstract][Full Text] [Related]
16. Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials.
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Frey A; Marr A; Roux S; Kassell NF
Neurocrit Care; 2010 Dec; 13(3):416-24. PubMed ID: 20838933
[TBL] [Abstract][Full Text] [Related]
17. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T
J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589
[TBL] [Abstract][Full Text] [Related]
18. Clazosentan: prevention of cerebral vasospasm and the potential to overcome infarction.
Beck J; Raabe A
Acta Neurochir Suppl; 2011; 110(Pt 2):147-50. PubMed ID: 21125461
[TBL] [Abstract][Full Text] [Related]
19. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
[TBL] [Abstract][Full Text] [Related]
20. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
